mylotarg 4.5 mg vial
ميلوتارج 4.5مجم فيال
gemtuzumabThe published official price. Pharmacies may differ slightly.
- Strength
- 4.5mg
- Form
- vial
- Manufacturer
- pfizer
- Route
- injection
The medical information below is guidance and may be incomplete or wrong. Do not change your medicine or dose based on it — ask a pharmacist or doctor.
Uses
Indicated for newly diagnosed or relapsed/refractory CD33-positive acute myeloid leukemia in eligible adult and pediatric patients.
Do not use if
Hypersensitivity to gemtuzumab or any component of the formulation.
Side effects
Common adverse effects include infection, fever, nausea, hemorrhage, fatigue, and infusion-related reactions.
Warnings
Can cause severe hepatotoxicity including veno-occlusive disease. Monitor liver function and infusion reactions closely.
How it works
CD33-directed antibody-drug conjugate that delivers a cytotoxic agent to leukemia cells expressing CD33.
Storage
Refrigerate at 2–8°C in the original carton. Do not freeze.